HLA-A and neoplasm: To test if 6B1 was able to recognize the naturally processed pIRS2 epitope presented by HLA-A*02:01 molecules, tumor cell lines that are HLA-A*02:01+ and pIRS2+ (15) (Supplemental Figure 1, B and C) were tested for the binding of 6B1 by flow cytometric analysis.